Work

FGF23‐mediated hypophosphatemia following saccharated ferric oxide administration during nutritional rehabilitation in anorexia nervosa: A case report

Year: 2026
Type: article
Study design: Case Report
Abstract: Background: Hypophosphatemia is a clinically important complication of nutritional rehabilitation in patients with anorexia nervosa (AN). Refeeding-related hypophosphatemia is often suspected initially. However, persistent hypophosphatemia despite phosphate supplementation or an atypical biochemical pattern should prompt evaluation for alternative causes. Intravenous iron is a recognized cause of fibroblast growth factor 23 (FGF23)-mediated hypophosphatemia. However, longitudinal documentation of intact FGF23 and renal phosphate handling before and after intravenous iron exposure during nutritional rehabilitation for severe AN remains limited. Case Presentation: ) was admitted for nutritional rehabilitation. She had severe iron-deficiency anemia and received intravenous saccharated ferric oxide. Hypophosphatemia developed despite prophylactic phosphate supplementation and persisted despite escalation of oral supplementation and the addition of intravenous phosphate replacement. Refeeding-related hypophosphatemia was initially suspected. However, the percentage tubular reabsorption of phosphate (%TRP) and tubular maximum reabsorption of phosphate per glomerular filtration rate (TmP/GFR) were markedly reduced during hypophosphatemia, indicating inappropriate renal phosphate wasting. Serial measurements demonstrated a transition from a normal pre-exposure intact FGF23 concentration (36.4 pg/mL) to marked FGF23 excess (782-838 pg/mL), followed by a progressive decline after iron withdrawal. Serum phosphate gradually recovered. No symptoms or organ dysfunction attributable to hypophosphatemia occurred. Conclusion: Hypophosphatemia during nutritional rehabilitation in AN should not automatically be attributed to refeeding-related mechanisms. Persistent hypophosphatemia despite supplementation, particularly when accompanied by renal phosphate wasting, should prompt reassessment of the underlying mechanism and evaluation for FGF23-mediated hypophosphatemia in patients exposed to intravenous iron.
Language: English
Subfield: Nephrology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,500
OpenAlex ID: W7236849114
FWCI:
Cites: 28
Cited by:
Related to: 10